Education Against Tobacco Randomized Trial in Brazil

Clinical Trial Summary

A two armed randomized trial is evaluating the effect of the medical-student-delivered school-based intervention Education Against Tobacco on the smoking behavior of adolescents in 7-11th grade of secondary school. The primary endpoint is the change in smoking prevalence between the two groups.

See also
Status	Clinical Trial	Phase
Completed	`NCT01164306` - The Impact of a Tobacco Control Intervention in African-American Families	N/A
Not yet recruiting	`NCT02731547` - Education Against Tobacco Randomized Trial in Bosnia and Herzegovina	N/A
Not yet recruiting	`NCT06399588` - Intervention for Adolescent Tobacco Initiation Prevention	N/A
Completed	`NCT02469779` - Middle and High School Students' Reactions to a Health Interactive Website: ASPIRE Reactions	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT01164306 - The Impact of a Tobacco Control Intervention in African-American Families

N/A

Not yet recruiting

NCT02731547 - Education Against Tobacco Randomized Trial in Bosnia and Herzegovina

N/A

Not yet recruiting

NCT06399588 - Intervention for Adolescent Tobacco Initiation Prevention

N/A

Completed

NCT02469779 - Middle and High School Students' Reactions to a Health Interactive Website: ASPIRE Reactions

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02725021
Study type	Interventional
Source	University of Giessen
Contact
Status	Active, not recruiting
Phase	N/A
Start date	October 2016
Completion date	April 2018

Education Against Tobacco Randomized Trial in Brazil

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms